Department of Physiology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA.
J Pharmacol Exp Ther. 2011 Dec;339(3):815-24. doi: 10.1124/jpet.111.184416. Epub 2011 Sep 22.
Although sex differences in asthma severity are recognized, the mechanisms by which sex steroids such as estrogen influence the airway are still under investigation. Airway tone, a key aspect of asthma, represents a balance between bronchoconstriction and dilation. Nitric oxide (NO) from the bronchial epithelium is an endogenous bronchodilator. We hypothesized that estrogens facilitate bronchodilation by generating NO in bronchial epithelium. In acutely dissociated human bronchial epithelial cells from female patients exposure to 17β-estradiol (E(2); 10 pM-100 nM) resulted in rapid increase of diaminofluorescein fluorescence (NO indicator) within minutes, comparable with that induced by ATP (20 μM). Estrogen receptor (ER) isoform-specific agonists (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol (THC) (ERα) and diaryl-propionitrile (DPN) (ERβ) stimulated NO production to comparable levels and at comparable rates, whereas the ER antagonist 7α,17β-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol (ICI 182,780) (1 μM) was inhibitory. Estrogen effects on NO were mediated via caveolin-1 (blocked using the caveolin-1 scaffolding domain peptide) and by increased intracellular calcium concentration [prevented by 20 μM 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl) ester but not by blocking Ca(2+) influx using LaCl(3)]. Estrogen increased endothelial NO synthase activation (inhibited by 100 μM N(G)-nitro-l-arginine methyl ester) and phosphorylated Akt. In epithelium-intact human bronchial rings contracted with acetylcholine (1 μM), E(2), THC, and DPN all produced acute bronchodilation in a dose-dependent fashion. Such bronchodilatory effects were substantially reduced by epithelial denudation. Overall, these data indicate that estrogens, acting via ERα or ERβ, can acutely produce NO in airway epithelium (akin to vascular endothelium). Estrogen-induced NO and its impairment may contribute to altered bronchodilation in women with asthma.
虽然已经认识到哮喘严重程度存在性别差异,但性激素(如雌激素)影响气道的机制仍在研究中。气道张力是哮喘的一个关键方面,代表着支气管收缩和扩张之间的平衡。支气管上皮细胞产生的一氧化氮(NO)是一种内源性支气管扩张剂。我们假设雌激素通过在支气管上皮细胞中产生 NO 来促进支气管扩张。在从女性患者中急性分离的人支气管上皮细胞中,暴露于 17β-雌二醇(E(2);10 pM-100 nM)在数分钟内导致二氨基荧光素荧光(NO 指示剂)快速增加,与 ATP(20 μM)诱导的增加相当。雌激素受体(ER)同工型特异性激动剂(R,R)-5,11-二乙基-5,6,11,12-四氢-2,8-胆甾二烯二醇(THC)(ERα)和二芳基丙腈(DPN)(ERβ)刺激 NO 产生的水平和速度相当,而 ER 拮抗剂 7α,17β-[9-[(4,4,5,5,5-五氟戊基)亚磺酰基]壬基]雌-1,3,5(10)-三烯-3,17-二醇(ICI 182,780)(1 μM)具有抑制作用。雌激素对 NO 的影响是通过 caveolin-1(使用 caveolin-1 支架结构域肽阻断)和细胞内钙浓度增加(用 20 μM 1,2-双(邻氨基苯氧基)乙烷-N,N,N',N'-四乙酸四(乙酰氧甲基)酯预防,但不能用 LaCl3 阻断 Ca2+内流)介导的。雌激素增加内皮型一氧化氮合酶的激活(用 100 μM N(G)-硝基-L-精氨酸甲酯抑制)和磷酸化 Akt。在乙酰胆碱(1 μM)收缩的完整人支气管环中,E(2)、THC 和 DPN 都以剂量依赖的方式产生急性支气管扩张。上皮细胞剥落后,这种支气管扩张作用明显减弱。总的来说,这些数据表明,雌激素通过 ERα 或 ERβ 作用,可在气道上皮细胞(类似于血管内皮细胞)中急性产生 NO。雌激素诱导的 NO 及其损害可能导致女性哮喘患者的支气管扩张发生改变。